Laurel Wealth Planning’s PetMed Express PETS Stock Holding History

Laurel Wealth Planning’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-300	Closed	-$10K	–	131
2020 Q4	$10K	Buy	+300	New	+$9.25K	0.01%	82

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Laurel Wealth Planning's PETS Position: Q1 2021 in Review

Laurel Wealth Planning sold out of PetMed Express (PETS) in Q1 2021, closing a stake of 300 shares — an estimated $10K sold.

Laurel Wealth Planning first reported a position in PETS in Q4 2020 and held it in 1 quarter. The position peaked at $10K in Q4 2020. 205 funds tracked by Wall St. Rank hold PETS as of Q1 2021.

Laurel Wealth Planning reported no remaining PetMed Express position as of Q1 2021 after selling out during the quarter.
Laurel Wealth Planning sold 300 PetMed Express shares in Q1 2021, an estimated $10K.
Laurel Wealth Planning first reported a position in PetMed Express in Q4 2020 and held it in 1 quarter.
Laurel Wealth Planning's PetMed Express position peaked at $10K in Q4 2020.
205 funds tracked by Wall St. Rank held PetMed Express as of Q1 2021.

Based on Laurel Wealth Planning's 13F filing for Q1 2021, filed 6 May 2021.